Skip to main content
OpenTrials

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,145 public trials 553 recruiting studies
Refine in advanced search Browse all conditions

Communicable Diseases trial results

Completed

The Safety and Effectiveness of Adefovir Dipivoxil in HIV-Infected Children

NCT00000843

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • UCSF / Moffitt Hosp - Pediatric San Francisco, California, United States
  • Univ of Florida Health Science Ctr / Pediatrics Jacksonville, Florida, United States
  • Chicago Children's Memorial Hosp Chicago, Illinois, United States
  • Johns Hopkins Hosp - Pediatric Baltimore, Maryland, United States
View Trial Details
Completed

A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection.

NCT00002126

Conditions
Acquired Immunodeficiency Syndrome, Agranulocytosis, Blood-Borne Infections, +21 more
Locations
  • Univ of Alabama at Birmingham / AIDS Outpatient Clinic Birmingham, Alabama, United States
  • Maricopa County Med Ctr Phoenix, Arizona, United States
  • CARE Ctr / UCLA Med Ctr Los Angeles, California, United States
  • UCSF - San Francisco Gen Hosp San Francisco, California, United States
View all 22 locations
View Trial Details
Completed

A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3

NCT00002185

Conditions
AIDS-Related Opportunistic Infections, Blood-Borne Infections, Communicable Diseases, +25 more
Locations
  • LAC and USC Med Ctr / School of Medicine Los Angeles, California, United States
  • Univ of California / UCI Med Ctr Orange, California, United States
  • UCSD Treatment Ctr San Diego, California, United States
  • Santa Clara Valley Med Ctr San Jose, California, United States
View Trial Details
Completed

A Randomized, Double-Blind Active-Controlled, Dose-Ranging Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected Patients

NCT00002151

Conditions
AIDS-Related Complex, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • Clinical Investigations Health Services Mobile, Alabama, United States
  • California Clinical Trials Med Group Beverly Hills, California, United States
  • Southwest Community Based AIDS Treatment Group - COMBAT Los Angeles, California, United States
  • UCSF - San Francisco Gen Hosp San Francisco, California, United States
View all 24 locations
View Trial Details
Completed

Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial

NCT00002267

Conditions
AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Actinomycetales Infections, +23 more
Locations
  • Maricopa County Med Ctr Phoenix, Arizona, United States
  • East Bay AIDS Ctr Berkeley, California, United States
  • Pacific Oaks Med Group Beverly Hills, California, United States
  • AIDS Community Research Consortium Redwood City, California, United States
View all 43 locations
View Trial Details
Completed

A Phase I/II Study of the Safety and Efficacy of Topical 1-(S)-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine Dihydrate (Cidofovir; HPMPC) in the Treatment of Refractory Mucocutaneous Herpes Simplex Disease in Patients With AIDS

NCT00002116

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +20 more
Locations
  • Los Angeles County - USC Med Ctr Los Angeles, California, United States
  • UCSF - San Francisco Gen Hosp San Francisco, California, United States
  • Mount Zion Med Ctr / UCSF San Francisco, California, United States
  • Rush Presbyterian - Saint Luke's Med Ctr Chicago, Illinois, United States
View Trial Details
Completed

Phase II Study of the Safety and Surrogate Marker Efficacy of Butyldeoxynojirimycin (SC-48334) and AZT in Symptomatic HIV-1 Infected Patients With 200 - 500 CD4+ Cells/mm3. (NOTE: Asymptomatic HIV-1 Infected Patients Also Eligible)

NCT00002079

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Dr Marcus Conant San Francisco, California, United States
  • Shared Med Research Foundation Tarzana, California, United States
  • Stratogen of South Florida Miami Beach, Florida, United States
  • Saint Joseph's Hosp / Infectious Disease Rsch Institute Tampa, Florida, United States
View Trial Details
Completed

The Safety and Effectiveness of Indinavir Sulfate Plus Efavirenz

NCT00002387

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • UCSD Treatment Ctr / Dept of Medicine & Pediatrics San Diego, California, United States
  • San Francisco Gen Hosp San Francisco, California, United States
  • Univ of Colorado / Health Science Ctr Denver, Colorado, United States
  • Hawaii AIDS Clinical Trial Unit Honolulu, Hawaii, United States
View Trial Details

Related conditions